Comparison Overview

Devicix by Nortech

VS

Alcon

Devicix by Nortech

7550 Meridian Circle N, Maple Grove, Minnesota, 55369, US
Last Update: 2025-03-04 (UTC)
Between 800 and 900

Strong

Devicix (www.devicix.com) is the engineering and product development services unit for Nortech. Devicix is an ISO 13485-certified and 14971-compliant, multi-disciplinary engineering firm that delivers innovative design solutions and comprehensive product development services exclusively to the medical device industry. With experienced professionals in Mechanical, Electrical, Software, Biomedical, and Industrial Engineering, Devicix is able to provide design excellence that meets the needs of our clients. We create Class I, II and III medical devices-in numerous and various medical specialties-including but not limited to: point-of-care diagnostic instruments, therapeutic devices, implantable devices and monitoring equipment. Devicix brings the foremost concept and product development expertise to early-stage and established medical device manufacturers, physicians, entrepreneurs and universities, allowing them to compete and win in todayโ€™s complex and heavily regulated global marketplace. Devicix also a member of the Medtech Resource Alliance; an exclusive group of experienced healthcare resource providers that focus on bringing the most innovative solutions to the most influential leaders in the medical community. For more information, visit us at www.Devicix.com or call (952) 905-2891.

NAICS: 3391
NAICS Definition: Medical Equipment and Supplies Manufacturing
Employees: 9
Subsidiaries: 0
12-month incidents
0
Known data breaches
0
Attack type number
0

Alcon

Avenue Louis-Casaรฏ 58, Geneva, Switzerland, 1216, CH
Last Update: 2025-05-06 (UTC)

Excellent

Between 900 and 1000

Alcon helps people see brilliantly. As the global leader in eye care with a heritage spanning over 75 years, we offer the broadest portfolio of products to enhance sight and improve peopleโ€™s lives. Our Surgical and Vision Care products touch the lives of more than 260 million people in over 140 countries each year living with conditions like cataracts, glaucoma, retinal diseases and refractive errors. Our more than 25,000 associates are enhancing the quality of life through innovative products, partnerships with Eye Care Professionals and programs that advance access to quality eye care. Learn more at www.alcon.com.

NAICS: 3391
NAICS Definition: Medical Equipment and Supplies Manufacturing
Employees: 26,196
Subsidiaries: 2
12-month incidents
0
Known data breaches
1
Attack type number
1

Compliance Badges Comparison

Security & Compliance Standards Overview

https://images.rankiteo.com/companyimages/devicix.jpeg
Devicix by Nortech
โ€”
ISO 27001
Not verified
โ€”
SOC 2
Not verified
โ€”
GDPR
No public badge
โ€”
PCI DSS
No public badge
https://images.rankiteo.com/companyimages/alcon.jpeg
Alcon
โ€”
ISO 27001
Not verified
โ€”
SOC 2
Not verified
โ€”
GDPR
No public badge
โ€”
PCI DSS
No public badge
Compliance Summary
Devicix by Nortech
100%
Compliance Rate
0/4 Standards Verified
Alcon
0%
Compliance Rate
0/4 Standards Verified

Benchmark & Cyber Underwriting Signals

Incidents vs Medical Equipment Manufacturing Industry Average (This Year)

No incidents recorded for Devicix by Nortech in 2025.

Incidents vs Medical Equipment Manufacturing Industry Average (This Year)

No incidents recorded for Alcon in 2025.

Incident History โ€” Devicix by Nortech (X = Date, Y = Severity)

Devicix by Nortech cyber incidents detection timeline including parent company and subsidiaries

Incident History โ€” Alcon (X = Date, Y = Severity)

Alcon cyber incidents detection timeline including parent company and subsidiaries

Notable Incidents

Last 3 Security & Risk Events by Company

https://images.rankiteo.com/companyimages/devicix.jpeg
Devicix by Nortech
Incidents

No Incident

https://images.rankiteo.com/companyimages/alcon.jpeg
Alcon
Incidents

Date Detected: 10/2021
Type:Breach
Attack Vector: Email
Blog: Blog

FAQ

Alcon company company demonstrates a stronger AI risk posture compared to Devicix by Nortech company company, reflecting its advanced AI governance and monitoring frameworks.

Alcon company has historically faced a number of disclosed cyber incidents, whereas Devicix by Nortech company has not reported any.

In the current year, Alcon company and Devicix by Nortech company have not reported any cyber incidents.

Neither Alcon company nor Devicix by Nortech company has reported experiencing a ransomware attack publicly.

Alcon company has disclosed at least one data breach, while Devicix by Nortech company has not reported such incidents publicly.

Neither Alcon company nor Devicix by Nortech company has reported experiencing targeted cyberattacks publicly.

Neither Devicix by Nortech company nor Alcon company has reported experiencing or disclosing vulnerabilities publicly.

Alcon company has more subsidiaries worldwide compared to Devicix by Nortech company.

Alcon company employs more people globally than Devicix by Nortech company, reflecting its scale as a Medical Equipment Manufacturing.

Latest Global CVEs (Not Company-Specific)

Description

An issue was discovered in chinabugotech hutool before 5.8.4 allowing attackers to execute arbitrary expressions that lead to arbitrary method invocation and potentially remote code execution (RCE) via the QLExpressEngine class.

Description

A weakness has been identified in JeecgBoot up to 3.8.2. The impacted element is an unknown function of the file /sys/role/exportXls. This manipulation causes improper authorization. It is possible to initiate the attack remotely. The exploit has been made available to the public and could be exploited. The vendor was contacted early about this disclosure but did not respond in any way.

Risk Information
cvss2
Base: 4.0
Severity: LOW
AV:N/AC:L/Au:S/C:P/I:N/A:N
cvss3
Base: 4.3
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:N
cvss4
Base: 5.3
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

A security flaw has been discovered in JeecgBoot up to 3.8.2. The affected element is an unknown function of the file /sys/user/exportXls of the component Filter Handler. The manipulation results in improper authorization. The attack may be performed from remote. The exploit has been released to the public and may be exploited. The vendor was contacted early about this disclosure but did not respond in any way.

Risk Information
cvss2
Base: 4.0
Severity: LOW
AV:N/AC:L/Au:S/C:P/I:N/A:N
cvss3
Base: 4.3
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:N
cvss4
Base: 5.3
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

A vulnerability was identified in JeecgBoot up to 3.8.2. Impacted is an unknown function of the file /sys/tenant/deleteBatch. The manipulation of the argument ids leads to improper authorization. The attack is possible to be carried out remotely. The complexity of an attack is rather high. The exploitability is considered difficult. The exploit is publicly available and might be used. The vendor was contacted early about this disclosure but did not respond in any way.

Risk Information
cvss2
Base: 2.1
Severity: HIGH
AV:N/AC:H/Au:S/C:P/I:N/A:N
cvss3
Base: 3.1
Severity: HIGH
CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:U/C:L/I:N/A:N
cvss4
Base: 2.3
Severity: HIGH
CVSS:4.0/AV:N/AC:H/AT:N/PR:L/UI:N/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

A vulnerability was determined in JeecgBoot up to 3.8.2. This issue affects some unknown processing of the file /api/getDepartUserList. Executing manipulation of the argument departId can lead to improper authorization. The attack can be executed remotely. This attack is characterized by high complexity. The exploitability is assessed as difficult. The exploit has been publicly disclosed and may be utilized. The vendor was contacted early about this disclosure but did not respond in any way.

Risk Information
cvss2
Base: 2.1
Severity: HIGH
AV:N/AC:H/Au:S/C:P/I:N/A:N
cvss3
Base: 3.1
Severity: HIGH
CVSS:3.1/AV:N/AC:H/PR:L/UI:N/S:U/C:L/I:N/A:N
cvss4
Base: 2.3
Severity: HIGH
CVSS:4.0/AV:N/AC:H/AT:N/PR:L/UI:N/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X